Purchases and Sales Made in Q2 2023 in Bright Minds Biosciences Inc. (DRUG)
This table provides information about the institutional ownership of Bright Minds Biosciences Inc. (DRUG) during Q2 2023. The information is specifically focused on institutions that hold shares of BRIGHT MINDS BIOSCIENCES INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 09, 2023
Q2 2023
|
Advisor Shares Investments LLC
Bethesda, MD |
BUY
|
- |
66.2K+ 14.73% |
$27.1K - $46.3K
|
515K
$20.3M
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
16.7KNew |
$6.86K - $11.7K
|
16.7K
$660K
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
332+ 15.95% |
$136 - $232
|
2.41K
$95.2K
|
|
Aug 10, 2023
Q2 2023
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
BUY
|
- |
21New |
$8.61 - $14.7
|
21
$829
|
|
Feb 14, 2024
Q2 2023
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
BUY
|
- |
21New |
$8.61 - $14.7
|
21
$829
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-8.8K- 80.75% |
$3.61K - $6.16K
|
2.1K
$82.8K
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-16.5K- 59.57% |
$6.77K - $11.6K
|
11.2K
$442K
|